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Abstract
Aim: This exploratory randomized, controlled clinical trial sought to evaluate
anti-inflammatory and -microbial effects of triclosan during experimental gingivi-
tis as assessed by host response biomarkers and biofilm microbial pathogens.
Materials and Methods: Thirty participants were randomized to triclosan or
control dentifrice groups who ceased homecare for 21 days in an experimental
gingivitis (EG) protocol. Plaque and gingival indices and saliva, plaque, and
gingival crevicular fluid (GCF) were assessed/collected at days 0, 14, 21 and 35.
Levels and proportions of 40 bacterial species from plaque samples were deter-
mined using checkerboard DNA-DNA hybridization. Ten biomarkers associated
with inflammation, matrix degradation, and host protection were measured from
GCF and saliva and analysed using a multiplex array. Participants were stratified
as “high” or “low” responders based on gingival index and GCF biomarkers and
bacterial biofilm were combined to generate receiver operating characteristic
curves and predict gingivitis susceptibility.
Results: No differences in mean PI and GI values were observed between groups
and non-significant trends of reduction of host response biomarkers with triclosan
treatment. Triclosan significantly reduced levels of A. actinomycetemcomitans and
P. gingivalis during induction of gingivitis.
Conclusions: Triclosan reduced microbial levels during gingivitis development
(ClinicalTrials.gov NCT01799226).
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Gingivitis is a reversible inflamma-
tory periodontal disease associated
with dental plaque. It appears in
high prevalence, with estimations of
more than half of the United States’
adults. (Loe et al. 1978, Eke et al.
2012).
The classic model of experimental
gingivitis (EG) was developed in
1965 by L€oe et al. and is routinely
used today to study the pathogenesis
and microbiologic changes from
health to gingivitis (Loe et al. 1965).
Most recently, this model has been
adapted to examine changes in oral
fluid inflammatory biomarkers (Lee
et al. 2012). This study identified
changes in 10 inflammatory
biomarkers and 40 pathogens during
induction and resolution of gingivitis
(EG). They also stratified subjects
based on their clinical inflammatory
response and used baseline levels of
salivary biomarkers to predict that
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response. Others have since con-
firmed these findings demonstrating
changes in gingival crevicular fluid
(GCF) biomarkers with induction of
gingivitis using this model or the tra-
ditional EG model (Heasman et al.
1993, Offenbacher et al. 2007, 2010,
Salvi et al. 2010, Trombelli et al.
2010, Farina et al. 2012, Scott et al.
2012, Eberhard et al. 2013).
Triclosan is a preservative and
broad-spectrum anti-microbial agent
(Jones et al. 2000). It has significant
anti-inflammatory properties by
inhibiting the cyclooxygenase and
lipoxygenase pathways of arachidonic
acid metabolism (Muller et al. 2006)
as well as host-derived inflammatory
mediators such as interleukin (IL) 1b,
IL-6, tumour-necrosis factor, and
prostaglandins (PG) (Modeer et al.
1996, Barros et al. 2010, Trombelli &
Farina 2013). Triclosan also signifi-
cantly reduces plaque, calculus, and
gingivitis, especially in patients who
have pre-existing established gingivi-
tis (Hioe & van der Weijden 2005,
Panagakos et al. 2005, Muller et al.
2006, Teles & Teles 2009, Vered et al.
2009, Riley & Lamont 2013). Addi-
tionally, when used in conjunction
with tooth brushing, it has also been
shown to reduce Fusobacteria and
Veillonella (Arweiler et al. 2002, Fine
et al. 2006) and to inhibit IL-1b, IL-
6, and PGE2 (Modeer et al. 1996,
Panagakos et al. 2005, Muller et al.
2006, Barros et al. 2010).
Stent models have been utilized
to evaluate anti-inflammatory effects
of triclosan dentifrice during EG.
While Saxton and colleagues found
superior reductions in plaque forma-
tion and gingivitis with triclosan as
compared to a control (Saxton &
van der Ouderaa 1989), others were
unable to demonstrate such clinical
differences (Saxton et al. 1993, Lang
et al. 2002). These studies, however,
only focused on clinical parameters
and contained dentifrice formula-
tions that are not currently avail-
able.
The aim of this exploratory study
was to assess the anti-inflammatory
effects of triclosan dentifrice com-
pared to a control during experimen-
tal gingivitis. The primary outcome
was to examine GCF biomarker
analytes. Periodontal clinical mea-
surements, microbial analysis, and





informed consent to the protocol
approved by the University of
Michigan Health Sciences Institu-
tional Review Board before adminis-
tration of research-related
procedures. The investigation was
conducted at the Michigan Center
for Oral Health Research in accor-
dance with the Helsinki Declaration
of 1975, as revised in 2000. The
inclusion and exclusion criteria of
the study population are outlined in
Appendix S1.
Clinical procedures
Figure 1 summarizes the study time-
line. A double-blind, controlled,
parallel group study modelling the
EG protocol originally described by
L€oe and Theilade was performed
(Loe et al. 1965). At screening (day
14) a periodontal evaluation, dental
prophylaxis, and oral hygiene instruc-
tion were performed (n = 78). Full-
mouth PD, recession (REC), CAL,
and BOP were recorded using a peri-
odontal probe at six sites per tooth
on all teeth except the third molars.
Participants provided a urine speci-
men to confirm their non-smoking
status. Pregnancy status was obtained
through questionnaires given at each
study visit. Mandibular alginate
impressions were taken and cus-
tomized stents were made by a single
examiner based on a modification of
a previously described study (Saxton
& van der Ouderaa 1989).
Appendix S2 provides a description
of the stent fabrication. At day 0
(baseline), if all inclusion and exclu-
sion criteria were met, participants
entered the experimental phase of the
trial. Participants who met all inclu-
sion criteria but had a BOP score of
>10% were given additional oral
hygiene instruction and returned in
2 weeks for a second assessment. Par-
ticipants not reaching a BOP score of
≤10% by the second confirmation
visit were not enrolled in the study.
Using an online randomization
chart, participants were assigned to
either the test (triclosan dentifrice)
or control (fluoride dentifrice) arm
of the study as well as to either the
right or left stent side. During the
induction phase (i.e., baseline to
21 days), participants were
instructed to refrain from all hygiene
procedures in the stent area. During
this time period, participants deliv-
ered a total of 2 ml of their assigned
dentifrice into their stent, allowing it
to come into contact with the areas
of EG for 2 min. twice daily while
traditional tooth brushing was per-
formed in the non-stent areas. A
complete description of participant
homecare instructions can be found
in Appendix S3.
The test dentifrice was composed
of 0.24% sodium fluoride 1100 ppm
0.243% (0.14% w/v fluoride ion)
and triclosan 0.30% in combination
with 2% polyvinyl methyl ether
maleic acid copolymer as the active
ingredients along with inactive
ingredients (Colgate Total Clean
Mint Paste, Piscataway, NJ, USA).
The control dentifrice was com-
posed of 0.76% sodium monofluo-
rophosphate 1000 ppm (0.15% w/v
fluoride ion) as the active ingredient
along with inactive ingredients (Col-
gate Cavity Protection Great Reg-
ular Flavor Fluoride Toothpaste).
Both dentifrice types were packaged
into identical white laminated tubes
so as to ensure appropriate mask-
ing.
At 21 days, participants received
a dental prophylaxis and reinstate-
ment of homecare oral hygiene
procedures from 21 to 35 days. All
study materials were collected and
compliance was assessed by calculat-
ing the amount of dentifrice used
(Almerich et al. 2005). Re-establish-
ment of gingival health was con-
firmed at day 35.
At days 0, 14, 21, and 35, the fol-
lowing data were collected in this
sequence: whole saliva, intra-oral
photos, GI, PI, plaque samples, and
GCF. Gingival index (GI) (Loe &
Silness 1963) and plaque index (PI)
(Silness & Loe 1964) were taken
from the stent quadrant Plaque and
GCF samples were collected from
the stent quadrant using a random-
ization chart to ensure no site was
sampled twice. Repeat GCF samples
were collected at 1, 2, 4, and 6 h
post-brushing at 14 and 21 days.
Five examiners underwent train-
ing and calibration procedures for
PD, REC, CAL, BOP, PI, and GI
prior to study initiation. Agreement
was reached within 1 mm or better
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for measures of PD, REC, and
CAL. For CAL measures, the mean
inter-examiner correlation coefficient
(using SPSS, Armonk, NY, USA)
was 0.478 and the mean intra-exami-
ner correlation coefficient (using
SPSS) was 0.648. For PI and GI,
rather a pre-study visual and tactile
examiner training was performed.
During the study, every attempt was
made to partner the examiner with
the same patient. Both participants
and examiners were masked to the
randomization scheme.
Whole saliva collection and analysis
Unstimulated whole saliva was col-
lected at the beginning of each visit
and processed as previously
described (Kinney et al. 2011).
Inflammatory biomarkers were
Fig. 1. Study timeline and recruitment and enrolment results of the study.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
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quantified using a custom human 10-
complex protein array that was
optimized for sensitivity, specificity,
stability, and intra-assay coefficient
of variation by comparing to single
cytokine enzyme-linked immunosor-
bent assays (Quantibody Custom
Array, RayBiotech, Norcross, GA).
Based on the results from Lee and col-
leagues, the 10-biomarker panel con-
sisted of: IL-1a, IL-1b, IL-6, IL-8, IL-
10, monocyte chemoattractant protein
(MCP)-1, MMP-8, MMP-9, TIMP-1,
and TIMP-2 (Lee et al. 2012).
Appendix S4 provides additional infor-
mation of the array procedures. Imme-
diately after whole saliva collection,
intra-oral photos were taken.
Microbial plaque collection and analysis
Supra- and sub-gingival plaque sam-
ples were collected using a sterile
curette from two sites within the
stent area. A randomization chart
ensured that each site in the
quadrant was sampled only once.
Samples were placed into vials con-
taining 150 ll of Tris-EDTA buffer
(10 mM Tris-HCl, 1 mM EDTA,
and 500 ml distilled water [pH 7.6]).
100 ll of 0.5 M NaOH was added
into each vial. Samples were stored
at 4°C until processed. Appendix S5
provides additional information
regarding microbial analysis. Detec-
tion of 40 bacterial species was
evaluated by the checkerboard
DNA-DNA hybridization technique
originally described by Socransky &
Haffajee 1994, (Socransky &
Haffajee 1994, Lee et al. 2012). The
species evaluated and their corre-
sponding microbial complexes are
listed in Fig. S1.
GCF collection and analysis
Gingival crevicular fluid samples
were collected at all study time
points from the same two sites as
the microbial plaque samples were
taken. At 14 and 21 days, GCF sam-
ples were collected, then patients
were instructed to place the denti-
frice in the stent and brush the rest
of their teeth for a 2 min. unsuper-
vised session. Repeat GCF samples
were collected from the same sites at
1, 2, 4, and 6 h post-brushing. A
methylcellulose strip (Pro Flow, Inc.,
Amityville, NY, USA) was kept
in place for 30 s and GCF was col-
lected as previously described (Gian-
nobile et al. 1995, Lamster & Ahlo
2007). Following collection, strips were
kept on dry ice for transport and then
stored at 80°C until analysis. The
samples were thawed and proteins
were extracted by an elution method
(Giannobile et al. 1995). A complete
description of the analysis procedures
can be found in Appendix S6. Ten
biomarkers were analysed based on
the results from Lee and colleagues:
IL-1a, IL-1b, IL-6, IL-8, IL-10, MCP-
1, MMP-8, MMP-9, TIMP-1, and
TIMP-2 (Lee et al. 2012).
Statistical analyses
See Appendix S7 for Comprehensive
Statistical Analyses performed in this
exploratory investigation.
Results
Figure 1 shows the CONSORT flow
chart of participant recruitment and
enrolment. Thirty participants com-
pleted the study; 14 in the control
arm (2 males and 12 females; mean
age: 27.1  5.2 years) and 16 in the
test arm (7 males and 9 females;
mean age 26.1  5.2 years). Table 1
depicts clinical and demographic
information of the patients. No signif-
icant differences were found between
the two groups in terms of race, age,
and clinical parameters (p > 0.05).
Clinical changes with induction of
gingivitis
Participants presented with high
BOP scores at the screening visit and
significantly reduced BOP scores at
the baseline visit (p < 0.001) with no
significant differences between the
two groups. During the induction
phase, significant increases in PI and
GI were observed in both groups
(p < 0.001) (Fig. 2a,b). A statistically
significant difference was detected
between groups at 14 days whereby
the test group had increased plaque
accumulation as compared to the
control group (p = 0.017). All clini-
cal parameters returned to baseline
values at day 35, with significant
differences seen from 21 days to
35 days in both groups (p < 0.001).
Microbial changes with induction of
gingivitis
Total bacterial counts and counts of
each microbial complex, except for
the grey complex, increased signifi-
cantly from baseline to 21 days and
decreased significantly from 21 to
35 days (p < 0.05) (Fig. 3a,b).
A. actinomycetemcomitans was
statistically significantly reduced in
the test group as compared to con-
trols from baseline to 14 days
(p = 0.013) and from baseline to
21 days (p = 0.038). Statistically sig-
nificant differences were also noted
for P. gingivalis, which was mark-
edly depressed by the triclosan denti-
frice from baseline to 14 days as
compared to control (p = 0.006).
GCF and salivary biomarker changes with
induction of gingivitis
Both groups demonstrated mirrored
and paralleled trajectories (Fig. 4).
Table 1. Participant demographics and clinical measures
Characteristics Test (frequency) Control (frequency) p-value
Gender 16 (100%) 14 (100%) NSD*
Male 7 (43.8%) 2 (14.3%)
Female 9 (56.3%) 12 (85.7%)
Race 16 (100%) 14 (100%) NSD*
African American 1 (6.3%) 1 (7.1%)
Asian 2 (12.5%) 2 (14.3%)
Caucasian 11 (68.8%) 9 (64.3%)
Hispanic 1 (6.3%) 1 (7.1%)
Other 1 (6.3%) 1 (7.1%)
Age, mean (SD) 26.06 (5.23) 27.07 (5.15) 0.60†
BOP at day 14 (SD) 0.47 (0.11) 0.49 (0.13) 0.66†
BOP at day 0 (SD) 0.09 (0.04) 0.10 (0.06) 0.62†
CAL at day 14, mean (SD) 0.76 (0.25) 0.75 (0.34) 0.93†
NSD, no significant difference.
*Fisher’s exact test.
†Independent samples t-test.
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GCF IL-1a and IL-1b increased sig-
nificantly from baseline to 21 days
(p < 0.05) and decreased significantly
during the recovery period for both
groups. IL-8 and MCP-1 were signif-
icantly reduced during induction
(p < 0.05) and increased during reso-
lution (p < 0.05). TIMP-1 and
TIMP-2 were significantly increased
with resolution of gingivitis only in
the test group (p < 0.05).
Though there were no significant
differences at any hourly time points
or areas under the curve (AUC)
between the groups at 14 days or
21 days (p > 0.05) (Figs S2 and S3),
several trends were noted.
No significant differences in sali-
vary biomarkers were noticed over
time or between dentifrice groups for
any of the biomarkers (Fig. S4).
Prediction of gingivitis response
Sixteen participants belonged to the
“high” responder group (9 test par-
ticipants and 7 control), whereas 14
participants belonged to the “low”
responder group (7 test participants
and 7 control). IL-1b was the best
single marker with an AUC of 0.64.
The best pair combination was IL-
1b and MMP-8 with an AUC of
0.71. The best trio combination was
IL-1b, MMP-8, and F. nucleatum ss
polymorphum with an AUC of 0.85
with an odds ratio of 2.96 (95% CI=
1.16, 7.57) of being a “high” respon-
der (Fig. 5).
Discussion
The aims of this exploratory study
were to assess how biomarkers and
pathogens are modulated by tri-
closan dentifrice when used during
induction of EG.
All patients developed gingivitis,
with similar increases in GI and PI to
previous studies (Loe et al. 1965,
Offenbacher et al. 2010, Salvi et al.
2010, Lee et al. 2012). Our inability
to demonstrate significant clinical dif-
ferences between groups remains con-
sistent with one study (Lang et al.
2002), yet contrasts with several other
studies (Saxton et al. 1993). Vered
et al. demonstrated remarkable
effects of triclosan over control denti-
frices when used for 6 months or
longer (Vered et al. 2009), though a
different study reported improved
anti-gingivitis activity as early as
6 weeks (Panagakos et al. 2005). The
underestimated actions of triclosan in
our study may be related to limita-
tions in our study design, specifically,
our rigid inclusion criteria and small
sample. As such, the effects of tri-
closan may not have been as dramatic
as when used in a situation beginning
with poorer oral hygiene, for exam-
ple. It has been reported that partici-
pants with higher baseline gingival
bleeding scores were more likely to
show reductions in bleeding and
inflammation using a triclosan denti-
frice in a 3-month clinical trial
(Shearer et al. 2005).
Interesting patterns of GCF bio-
marker results emerged, especially
when comparing the study day (0,
14, 21, 35) longitudinal findings to
repeat sampling at 0, 1, 2, 4 and 6 h
post-dentifrice exposure. As
expected, overall IL-1b levels
increased in both groups during the
induction phase of the study (day 0
to 21). Our results mirror those pre-
viously reported in other EG studies
(Zhang et al. 2002, Trombelli et al.
2006, and Salvi et al. 2010). How-
ever, a marked drop in both IL-1a
and IL-1b concentrations was
observed in both the test and con-
trols groups at 14 days and 21 days
1 h post-dentifrice application. Fur-
thermore, a continued sustained
reduction in IL-1a levels was seen
for 6 h post exposure. Regarding IL-
8 production, our results are similar
to others (Zhang et al. 2002, Deinzer
et al. 2007, Lee et al. 2012) and
showed a short-term down-regula-
tion of this biomarker, especially
early in the early stages of experi-
mental gingivitis. What is notewor-
(a)
(b)
Fig. 2. A statistically significant increase in the plaque index and gingival index was
noted with gingivitis induction as well as a statistically significant decrease with resolu-
tion (p < 0.001). At day 14, the test group had a statistically significantly higher
plaque index compared to the control group (¥p = 0.017).
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thy is that our repeat IL-8 GCF
sampling results at 14 days and
21 days showed a strong increase in
this cytokine up to 2 h post-denti-
frice application. After 2 h of
dentifrice exposure levels of IL-8
appeared to plateau off, but were
still elevated from pre-application
concentrations. Other GCF biomar-
ker differences were observed
between the mean study day levels
and the repeated sampling levels at
14 and 21 days. For example, while
mean levels of MCP-1 decreased
from day 0 to 14 and 21 days, post-
dentifrice contact levels 1, 2, 4 and
6 h steadily rose. A similar trend
was seen in the mean levels of
TIMP-2. There was an overall
decrease in the concentrations of this
biomarker during the induction
phase of the study; yet repeat post-
dentifrice contact levels rose at 14
and 21 days.
The uniqueness of the model per-
mitted evaluation of the effects of
triclosan in the absence of tooth
brushing and eliminated participant
differences in oral hygiene practices
as a potential bias. Furthermore, the
model demonstrated differences in
biomarker concentrations within
hours after using the therapeutic
agent. At 14 days, triclosan demon-
strated trends of depressing levels of
MMP-8 and -9 and TIMP-1 at 2
and 4 h after application through
the stent. It was also able to main-
tain these depressed levels over the
6 h after application in MMP8 and
TIMP-1. Furthermore, triclosan
increased TIMP-2 levels just hours
after its application on 21 days as
demonstrated by the AUC analysis.
This clearly demonstrates that tri-
closan has an immediate effect
(within hours) in depressing levels of
enzymes that destroy collagen in the
early stages of gingivitis induction.
In addition, after the depressed
effects on the matrix degradation
enzymes, triclosan was then able to
increase the concentration of their
inhibitors, further protecting the
periodontium from destruction.
Based on our current knowledge,
this is the first study demonstrating
the anti-microbial effects of triclosan
through DNA-DNA hybridization
when used as a locally applied agent
without the use of mechanical tooth
brushing. The test group was found
to have statistically significantly
depressed changes in counts of Por-
phyromonas gingivalis and Aggregati-
bacter actinomycetemcomitans, as
well as demonstrated trends for
depressed levels of Tannerella for-
sythia. Changes in Actinomyces spe-
cies were also found to be depressed,
although not statistically significant,
in the test as compared to the con-
trol. These species are commonly
associated with developing gingivitis
(Loesche & Syed 1978, Slots 1979,
Mombelli et al. 1990). The test
group also demonstrated a trend for
decreased levels of Peptostreptococ-
cus micra and Fusobacterium nuclea-
tum. P. micra has been shown to
increase in gingivitis (Slots 1979,
Mombelli et al. 1990) chronic peri-
odontitis, and active progressive
periodontal disease (Rams et al.
1992). Furthermore, its elimination
has been associated with clinical
improvement (Haffajee et al. 1988).
F. nucleatum is a key component of
the biofilm as it possesses the ability
to coaggregate with multiple species
in the oral cavity and bridge primary
colonizers found in gingivitis with
secondary colonizers such as P. gin-
givalis found in periodontitis (Yang
et al. 2014).
Fig. 3. Blue line delineates bacterial counts in the test group. Orange fill represents
bacterial counts in the control group.
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Our findings remain consistent
with former studies that demonstrate
the benefit of triclosan dentifrice over
a control when used in conjunction
with tooth brushing (Arweiler et al.
2002, Fine et al. 2006). In this study
we see declines in these microbial
reductions, however, they were found
to diminish considerably when metic-
ulous patient home care and profes-
sional debridement was performed
(Teles & Teles 2009). It is possible
that trends and non-significant differ-
ences were noted in our study due to
the small patient sample and extre-
mely meticulous oral hygiene
required by the participants prior to
cessation of oral hygiene. Had the
patients entered the experimental
phase of the study with high levels of
plaque and inflammation, it is possi-
ble that the effects of treatment may
have been more noticeable. It is also
possible that the anti-microbial and
anti-inflammatory functions of tri-
closan may have been limited as a
result of its placement and possible
absorption into a thick, experimen-
tally induced plaque filled surface. As
such, we propose that the active
chemical components, triclosan and
fluoride, remain effective when used
in conjunction with tooth brushing.
Baseline values of the combina-
tion of IL-1b, MMP-8, and F.
nucleatum ss polymorphum had the
best ability to discriminate between
“high” versus “low” responders.
Doubling baseline values of IL-1b
while controlling for MMP-8 and F.
nucleatum ss polymorphum is associ-
ated with 3x the odds of displaying
an exaggerated inflammatory
response compared to those with
low levels of at least one of these
markers. MMP-8 was also shown to
play an important role in predicting
the inflammatory response. While
our study did not demonstrate
remarkable changes in this biomar-
ker with gingivitis induction, others
have shown an increase in MMP-8
with cessation of oral hygiene
(Offenbacher et al. 2010, Salvi et al.
2010). Additionally, F.nucleatum as a
bridging species has been found to
predominate in gingivitis (Listgarten
1976, Slots 1979, Mombelli et al.
1990). In fact, Lee and colleagues
also determined that this microbe
predisposed participants to be at
higher risk of gingivitis (Lee et al.
2012). Thus, “high” responders pos-
sess a specific microbial profile and
immuno-inflammatory phenotype at
baseline, which predicts colonization
of periodontal pathogens and inflam-
matory cytokines.
Our exploratory study identified
changes in host immune and micro-
bial biomarkers that transpire during
the pathogenesis of gingival inflam-
mation. Though our pilot study was
unable to demonstrate superior clini-
cal effects, we did detect depressed
levels in microbes and inflammatory
GCF biomarkers during gingivitis
development with the use of tri-
closan applied through a stent
model. The test group demonstrated
an increased ability to reduce Actino-
myces species, red complex patho-
gens, A. actinomycetemcomitans, and
bridging organisms F. nucleatum and
P. micra with induction of gingivitis.
Fig. 4. GCF IL-1a and IL-1b significantly increased with gingivitis induction (IL-1a;
*p < 0.001, †p = 0.005) (IL-1b; *p < 0.001, †p = 0.004) and decreased with resolution
(IL-1a; *p = 0.006, †p < 0.001) (IL-1b; *p = 0.020, †p = 0. 033). IL-8 and MCP-1 sig-
nificantly decreased with gingivitis induction (IL-8; *p < 0.001, †p = 0.004) (MCP-1;
*p = 0.046, †p = 0.004) and increased with resolution (IL-8; *p < 0.001, †p < 0.001)
(MCP-1; *p = 0.039, †p = 0.0.03). No significant differences in matrix degradation
enzymes were observed. TIMP-1 and TIMP-2 significantly increased with resolution
of gingivitis in the test group (TIMP-1; †p = 0.020) (TIMP-2; †p = 0.009).
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Triclosan also depressed levels of
MMPs within a few hours after tri-
closan application early on in gin-
givitis development along with an
increase in protective inhibitors of
matrix degradation enzymes at the
later stages of gingivitis develop-
ment. By identifying highly suscepti-
ble patients, early identification,
diagnosis, and therapeutic interven-
tion may be provided prior to irre-
versible attachment loss. Given the
nature of this exploratory trial,
future larger randomized controlled
clinical trials should be directed
towards investigating a cluster of
biomarkers affected by gingivitis
along with therapeutic modalities
that best reduce their immuno-
inflammatory and microbial compo-
nent.
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Fig. S1. 40 Microbial pathogens and
their respective complexes analysed
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hybridization technique.
Fig. S2. No significant differences in
pro-inflammatory cytokines were
observed over time at day 14.
Fig. S3. There was a trend for higher
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salivary biomarkers were observed.
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Scientific rationale for the study:
The effects of triclosan dentifrice
on oral fluid biomarkers in the
absence of mechanical plaque
removal are unknown.
Principal findings: Local applica-
tion of triclosan demonstrated an
ability to reduce microbial patho-
gens, of particular interest red com-
plex pathogens and bridging
organisms. It also lowered levels of
matrix metalloproteinases early in
the development of experimental gin-
givitis while increasing levels of pro-
tective inhibitors of collagen
degradation enzymes later in the
gingivitis state.
Practical implications: The use of a
triclosan dentifrice may be consid-
ered a therapeutic intervention to
alter the oral microbiome in
patients with gingivitis.
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